{
    "2021-08-10": [
        [
            {
                "time": "",
                "original_text": "调研回录|健帆生物（300529.SZ）：衡阳本次地方集采对公司影响很小 预判短期不会被纳入全国性集中带量采购范围",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "地方集采",
                        "全国性集采",
                        "影响很小"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "健帆生物聘任外籍高管 大力开拓海外市场",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "外籍高管",
                        "海外市场",
                        "开拓"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "子女买入公司股票后六个月内卖出 健帆生物董事会主席收警示函 金融监管处罚",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "董事会主席",
                        "警示函",
                        "金融监管",
                        "处罚"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "健帆生物：聘任Caroline Xiaoku Jin为副总经理",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "Caroline Xiaoku Jin",
                        "副总经理",
                        "聘任"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "健帆生物(300529.SZ)聘任Caroline Xiaoku Jin为副总经理",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "Caroline Xiaoku Jin",
                        "副总经理",
                        "聘任"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "健帆生物监事会主席彭小红收警示函 子女违法减持 董监高成员异常事件",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "监事会主席",
                        "彭小红",
                        "警示函",
                        "违法减持",
                        "董监高成员"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}